Acute myeloid leukemia (AML) is a cancer of the myeloid line of blood cells, characterized by the rapid growth of abnormal cells that build up in the bone marrow and blood that interfere with normal blood cells. It’s sometimes called acute myelocytic, myelogenous or granulocytic leukaemia. [1] Causes of AML The causes of AML remain largely […]

Read More →

Health Canada (HC) reviews, evaluates, and approves applications for clinical trials using authorized therapeutic products in Canada. HC assesses clinical trial protocols to evaluate participant protection and safety; reviews drug quality; assures institutional ethics committee review; verifies principal investigator qualifications; and monitors and reviews adverse drug reactions. HC also approves the sale or importation of […]

Read More →